Learn how we can support you at ECCMID 2024
Every diagnosis carries the weight of a patient's hopes and fears. But with just one test, you can lighten the load.
That's why we're here – to help you shoulder the burden of diagnosis. From pinpointing early signs of disease, to providing swift answers in emergencies, our cutting-edge technology can give you the clarity to confidently move forward.
Come chat with us at ECCMID booth D20 to learn how we can work together to give patients peace of mind, swift answers and the power to take control of their health.
Our ECCMID 2024 program
Get up close and personal with our instruments.
Must-have for your ECCMID agenda: Diagnostic Insights sessions at booth D20
10:15 – 10:45 a.m.
Pathogen detection with Deep Technologies: A new frontier in microbiological diagnosis
Prof. Stefania Stefani, Professor of Microbiology and Clinical Microbiology, University of Catania, Italy
12:15 – 12:45 p.m.
Navigating epidemiological co-detection trends with QIAstat-Dx syndromic testing and QIAsphere Insights
Ricard Martin, Associate Director, Global Product Management, Syndromic Testing, QIAGEN
3:30 – 4:00 p.m.
QIAstat-Dx Rise: Our experience with implementing GI and respiratory syndromic testing in routine diagnostics
Christoffer Lindsten, Molecular biologist, Microbiology Halland, Region Halland, Sweden
10:15 – 10:45 a.m.
Introducing a breakthrough in Tuberculosis whole genome sequencing
Dylan Barbera, Global Product Manager, UNGS Genotyping, QIAGEN
Federico Di Marco, Emerging Bacterial Pathogens, Unit Div. of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute
12:15 – 12:45 p.m.
The impact of STEC diagnostics on hemolytic uremic syndrome and the rise of the stx2f subtype
Carmen Miravet Zaragoza, Medical Science Liaison, QIAGEN
10:15 – 10:45 a.m.
Quantitative molecular solutions in HIV care: From RNA monitoring with NeuMoDx to intact proviral DNA testing with QIAcuity
Dr. Martin Obermeier, Laboratory Director, Medical Center for Infectious Diseases, Berlin, Germany
12:15 – 12:45 p.m.
Clinical impact of the implementation of a meningitis/encephalitis syndromic panel in a tertiary care hospital
José-Román Muñoz del Rey, Specialist in Microbiology and Parasitology at Virgen del Puerto Plasencia Hospital, Spain
3:30 – 4:00 p.m.
Monitoring CMV cellular immunity in renal transplant patients: From validation to clinical implementation
Dr. Pablo González-Calero, Clinical Nephrologist, Hospital Universitario La Fe (Valencia), Spain
Our diagnostic tools
Our clinical resources
Watch on-demand clinical webinars
Watch on-demand clinical webinars
Featured products
** The QIAcuityDx digital PCR system, as an IVD medical device, is under development and has not yet been placed on the market.
Product availability may differ from country to country based on regulations and approvals. Contact your country representative for further details.
For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN/NeuMoDx kit instructions for use or user operator manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor) or www.neumodx.com/client-resources